{"id":"https://genegraph.clinicalgenome.org/r/eca7be84-0b23-48a8-a7c1-93e10e7b6cdav1.0","type":"EvidenceStrengthAssertion","dc:description":"There has been sufficient amount of evidence published associating the MSH2 gene with constitutional mismatch repair deficiency syndrome - a distinct disorder from the dominant Lynch syndrome - since the gene-disease relationship was first proposed by Whiteside D, et al., (2002). Multiple case level studies have been performed with cMMRD syndrome patients that have variants in the MSH2 gene. Other mismatch repair (MMR) genes MLH1, MSH6 and PMS2 also causes constitutional mismatch repair deficiency syndrome. RNA and Immunoblotting demonstrate a lack of MSH2 protein in patient cells. Multiple MSH2 deficient mouse and zebrafish models have been established to show consistent phenotypes with cMMRD patients by developing neurofibromas and lymphoid tumors. There is sufficient  evidence consistent with a definitive relationship between the MSH2 gene and constitutional mismatch repair deficiency syndrome.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/eca7be84-0b23-48a8-a7c1-93e10e7b6cda","GCISnapshot":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-10-09T14:44:00.302Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd247877-edb6-449d-a8fe-3bd5f4a04319","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8777c7df-69e2-465c-9050-c4b4b75f1ab9","type":"Finding","dc:description":"MSH2-deficient mice develop lymphoid tumors with high frequency that contained microsatellite instabilities.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7550317","rdfs:label":"MSH2 deficient mice are susceptible to lymphoid tumours.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/81ca0f96-0927-408f-86c5-e008356d86c2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9fdaed16-ca72-4d7b-bf51-825c9711c9fd","type":"Finding","dc:description":"MSH2 -/- mutant zebrafish develop neurofibromas/malignant peripheral nerve sheath tumors and other tumors.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18593904","rdfs:label":"MMR-deficient zebrafish develop neurofibromas & other tumors","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/573558c9-a033-4329-8347-d3afb7b7d2d8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5ff34fdf-b5ce-4b72-a353-64cb34eb61b8","type":"Finding","dc:description":"Mismatch bound MutSa (MSH2 and MSH6) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. PMS2 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10763829","rdfs:label":"PMS2 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ad1824d8-783d-4cb1-ae8a-c49b0b55e42f","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78fe9a3c-3061-4957-b383-a2be3e7652d9","type":"Finding","dc:description":"Mismatch bound MutSa (MSH2 and MSH6) recruits a second heterodimer referred to as MutLa which is composed of the MutL homologs MLH1 and PMS2. MLH1 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9927034","rdfs:label":"MLH1 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/946df61c-d0c9-4401-a99c-ca8cdee855f6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f64d16ec-dd6a-4dc9-a387-9da4a9972db8","type":"Finding","dc:description":"In humans mismatch recognition is mediated by one of two heterodimers, composed of the MutS homologs MSH2 and MSH6 (MutSa) or MSH2 and MSH3 (MutSb). MSH6 also causes constitutional mismatch repair deficiency syndrome.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/15340263","rdfs:label":"MSH6 – constitutional mismatch repair deficiency syndrome","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/1e856081-e7fa-4c9d-ab79-0bde10c315a3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2a14c488-44a6-4eb0-94ba-91b055b5b556","type":"Finding","dc:description":"Sequence of cDNA across exon 10 and 12, demonstrating the skipping of exon 11 (Figure 3B). Western blotting using MSH2 antibody demonstrates a lack of MSH2 protein (Figure 3C).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11809679","rdfs:label":"RNA and Immunoblotting demonstrate a lack of MSH2 protein","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cefaff78-0d63-4276-88f8-38d07a39d878_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The adenocarcinoma cells and the normal cells show loss of nuclear staining for MSH2 (Fig. 3b, c). The c.1906G>C mutation is a founder mutation in the Ashkenazi Jewish population. It is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/693f519d-e653-471b-b5b1-7e410db825e8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19101824","rdfs:label":"A 14-year-old boy","ageType":"AgeAtReport","ageUnit":"Years","ageValue":14,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0009592","obo:HP_0000957","obo:HP_0003003"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cefaff78-0d63-4276-88f8-38d07a39d878_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19101824","allele":{"id":"https://genegraph.clinicalgenome.org/r/a8df00e6-13d7-426b-84b0-47182ebfece0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000251.2(MSH2):c.1906G>C (p.Ala636Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1764"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/05dac5fc-d3c8-47b9-997e-75746237411e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous G-to-A transition was found in the proband in the invariant G of the intron 10 acceptor site of the MSH2 gene. This mutation at position 1662-1 bp was predicted to result in skipping of exon 11 to exon 12, with out-of-frame translation of the mutant mRNA resulting in a truncated, nonfunctional protein. RNA and Immunoblotting demonstrate a lack of MSH2 protein. It is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/666bb46e-fed0-4f2d-92b5-bee53847aa6a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11809679","rdfs:label":"The proband","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":24,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0006727","obo:HP_0000957"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/05dac5fc-d3c8-47b9-997e-75746237411e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11809679","allele":{"id":"https://genegraph.clinicalgenome.org/r/541ffdcc-c69b-4252-94fc-6de50aaaea38","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000251.2(MSH2):c.1662-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/90727"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/869a7f39-4c6e-4d20-b4a7-87463143e327_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Immunohistochemistry did not detect expression of MSH2 in the tumor and surrounding normal tissue. A homozygous T-to-A transversion in intron 12 of the MSH2 gene. The mutation is predicted to create an aberrant splice site, resulting in the skipping of exon 13 and creation of a premature stop codon at position 676, thus producing a truncated protein. It is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/695be68b-1e93-4941-88d8-296b6f221a09","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16372347","rdfs:label":"The 11-year-old patient","ageType":"AgeAtReport","ageUnit":"Years","ageValue":11,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0003003","obo:HP_0005227","obo:HP_0000957"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/869a7f39-4c6e-4d20-b4a7-87463143e327_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16372347","allele":{"id":"https://genegraph.clinicalgenome.org/r/2a9ca225-0aeb-42f7-8c44-79d8dcd6f28a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000251.2(MSH2):c.2006-5T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/90849"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/f1ebc583-8134-43b5-b9f8-204f443372b6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A homozygous truncating mutation in exon 2 of MSH2 (226C>T; Q76X). It is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c56ed4d-2e99-4959-a05f-3cd4f6ccd475","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17601929","rdfs:label":"IV-2","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0001010","obo:HP_0012539"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f1ebc583-8134-43b5-b9f8-204f443372b6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17601929","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf06c672-0b5d-444d-b6cc-8a5cba26035c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000251.2(MSH2):c.226C>T (p.Gln76Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/90945"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/df478a7c-9ca0-4d03-8f97-9a33ee3b929d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19101824","rdfs:label":"Ashkenazi Jewish family","estimatedLodScore":2.23,"family":{"id":"https://genegraph.clinicalgenome.org/r/df478a7c-9ca0-4d03-8f97-9a33ee3b929d","type":"Family","rdfs:label":"Ashkenazi Jewish family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/693f519d-e653-471b-b5b1-7e410db825e8"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":13,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0009592","obo:HP_0003003","obo:HP_0000957"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/693f519d-e653-471b-b5b1-7e410db825e8"}},{"id":"https://genegraph.clinicalgenome.org/r/5466a93d-2b68-4e6c-8a30-1b60698f6d0f_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16372347","rdfs:label":"Two brothers","estimatedLodScore":1.1,"family":{"id":"https://genegraph.clinicalgenome.org/r/5466a93d-2b68-4e6c-8a30-1b60698f6d0f","type":"Family","rdfs:label":"Two brothers","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/695be68b-1e93-4941-88d8-296b6f221a09"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":4,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0003003","obo:HP_0000957","obo:HP_0005227"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/695be68b-1e93-4941-88d8-296b6f221a09"}},{"id":"https://genegraph.clinicalgenome.org/r/0bf02369-55d5-40c8-b0c3-e64f834214e9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12549480","rdfs:label":"2 sibs","estimatedLodScore":4.23,"family":{"id":"https://genegraph.clinicalgenome.org/r/0bf02369-55d5-40c8-b0c3-e64f834214e9","type":"Family","rdfs:label":"2 sibs","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/5bb953a0-94a5-4aa0-aad7-378bead8e3ec","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12549480","rdfs:label":"IV-2","ageType":"AgeAtDeath","ageUnit":"Months","ageValue":15,"detectionMethod":"Quantitative multiplex PCR of short fluorescent fragments (QMPSF)","firstTestingMethod":"PCR","phenotypes":["obo:HP_0100843","obo:HP_0006727"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4667acd9-9cb4-4c1c-88b9-f6cb855af9f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12549480","allele":[{"id":"https://genegraph.clinicalgenome.org/r/34bbec9d-69f2-434e-a980-a286f3e33130","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000251.2(MSH2):c.454delA (p.Met152Cysfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1768"}},{"id":"https://genegraph.clinicalgenome.org/r/dbd4b9b3-b462-4d7a-9870-0b19bf5163a7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"MSH2, EX1-6 DEL","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/1767"}}],"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":29,"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0100843","obo:HP_0006727"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/5bb953a0-94a5-4aa0-aad7-378bead8e3ec"}},{"id":"https://genegraph.clinicalgenome.org/r/a38d2e3a-0581-422a-bd63-a7ffa0501d2a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11809679","rdfs:label":"The family","estimatedLodScore":1.62,"family":{"id":"https://genegraph.clinicalgenome.org/r/a38d2e3a-0581-422a-bd63-a7ffa0501d2a","type":"Family","rdfs:label":"The family","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/666bb46e-fed0-4f2d-92b5-bee53847aa6a"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":13,"phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0000957","obo:HP_0006727"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/666bb46e-fed0-4f2d-92b5-bee53847aa6a"}},{"id":"https://genegraph.clinicalgenome.org/r/7297be57-2774-44a7-8d92-1485b701fac2_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17601929","rdfs:label":"FACT24","estimatedLodScore":4.45,"family":{"id":"https://genegraph.clinicalgenome.org/r/7297be57-2774-44a7-8d92-1485b701fac2","type":"Family","rdfs:label":"FACT24","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/4c56ed4d-2e99-4959-a05f-3cd4f6ccd475"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypeNegativeAlleleNegative":26,"phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0001010","obo:HP_0012539"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/4c56ed4d-2e99-4959-a05f-3cd4f6ccd475"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/4667acd9-9cb4-4c1c-88b9-f6cb855af9f9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Kets et al. (2009) found compound heterozygosity for 2 variants in the MSH2 gene: an exon 1-6 deletion and 1A-G transition in the initiation codon. Met152Cysfs is a three star variant reviewed by International Society for Gastrointestinal Hereditary Tumours (InSiGHT).","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5bb953a0-94a5-4aa0-aad7-378bead8e3ec"}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":515,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/3M42G5BETM8","type":"GeneValidityProposition","disease":"obo:MONDO_0010159","gene":"hgnc:7325","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_7ce2b2b9-9b04-4a47-b6fa-b85c60ba1c08-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}